Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
25 drugs in development
By Therapeutic Area
top 6
R&D Momentum
100/100
Pipeline Velocity
84/100
Trial Completion Rate
72/100
Pipeline Concentration
20/100
Pipeline Freshness
72/100
Strategic Signals
Activity
Last 14 days
The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control Through PrEP (IN-STEP) Study
Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes
Accelerated Flap Coverage Versus Standard Timing in the Treatment of Severe Lower Extremity Musculoskeletal Injuries
Development and Incorporation of Safe Sleep Education Into m-Health Technology for the Pediatric Emergency Department
Autologous Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Femoral Head
Advancing Bulbar Assessment in Inclusion Body Myositis Through a Multimodal Imaging Approach
PRoMiSS: Psilocybin and the Role of Music in Set and Setting
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)